Collegium Pharmaceutical, Inc (COLL) dividend history

COLLNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/3045% below fair value

$24.95+0.14 (+0.56%)

Close on Nov 12, 2026Market cap $812.26MP/E 24.9Yield –

Dividends

No dividend per share appears in Collegium Pharmaceutical's annual filings since fiscal 2012.

Parsed from the XBRL in Collegium Pharmaceutical's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is COLL.

Revenue growth7.7% · median 25.9%

Gross margin59.0% · median 82.3%

Operating margin15.2% · median 10.2%

Net margin4.7% · median 11.2%

Advertisement
300 × 250

See a number that looks wrong?